NCT04800822 2024-10-22PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT04541407 2023-05-16Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS DiseaseUniversity of Colorado, DenverPhase 1 Completed1 enrolled